Nanotechnology has the potential to circumvent several drawbacks of conventional
therapeutic formulations. In fact, significant strides have been made towards the application …

Cancer stem cells (CSCs) are a subpopulation of cancer cells with functions similar to those
of normal stem cells. Although few in number, they are capable of self-renewal, unlimited …

Combination therapy and nanotechnology offer a promising therapeutic method in cancer
treatment. By improving drug's pharmacokinetics, nanoparticulate systems increase the …

Cancer stem cells (CSCs) are a small subpopulation of cells within a tumor that can both self‐
renew and differentiate into other cell types forming the heterogeneous tumor bulk. Since …

This combinational therapy is mainly aimed for complete eradication of tumor by killing both
cancer cells and cancer stem cells. Salinomycin (SLM) was targeted towards cancer stem …

It is verified that failure in cancer therapy by conventional chemotherapeutic agents arise
from cancer heterogeneity. That, a small subpopulation of cancer cells known as “cancer …

The emerging concept of cancer stem cells (CSCs) as the key driver behind carcinogenesis,
progression, and diversity has displaced the prior model of a tumor composed of cells with …

One limiting factor of CAR T-cell therapy for treatment of solid cancers is the suppressive
tumor microenvironment (TME), which inactivates the function of tumor-infiltrating …

Cancer stem cells (CSCs) are the promising targets for cancer chemotherapy that cannot be
eliminated by conventional chemotherapy. In this study cationic liposomes of cabazitaxel …

Purpose Conventional chemotherapy is hampered by the presence of breast cancer stem
cells (BCSCs). It is crucial to eradicating both the bulky breast cancer cells and BCSCs …